August 12, 2025 — Leads & Copy — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) announced it has secured a five-year, $45 million term loan facility with Trinity Capital Inc. Proceeds will support global commercial expansion of the Growth Direct system, manufacturing efficiencies, service productivity, and product cost reduction initiatives.
The loan facility includes an initial $20 million draw at closing, with access to up to an additional $25 million contingent on achieving specific commercial and operational milestones. The interest rate is initially set at 11.5% per annum. Armentum Partners acted as the Company’s exclusive financial advisor on this transaction.
Robert Spignesi, President and CEO of Rapid Micro Biosystems, stated the facility strengthens the company’s financial position and supports long-term revenue growth and increasing shareholder value.
Rapid Micro Biosystems Investor Contact: Michael Beaulieu, CFA Vice President, Investor Relations and Corporate Communications investors@rapidmicrobio.com Rapid Micro Biosystems Media Contact: media@rapidmicrobio.com
Source: Rapid Micro Biosystems
